Understanding: What Are the Premedications for Paclitaxel?
•
4 min read
In early clinical trials, between 25% and 40% of patients experienced a hypersensitivity reaction (HSR) to paclitaxel, prompting the development of standard premedication regimens. These premedications are crucial for mitigating adverse events associated with paclitaxel infusions, particularly severe allergic reactions that can be life-threatening.